CCKBR
Basic information
Region (hg38): 11:6259806-6272127
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCKBR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 29 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 29 | 0 | 2 |
Variants in CCKBR
This is a list of pathogenic ClinVar variants found in the CCKBR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-6259936-T-G | not specified | Uncertain significance (Aug 13, 2021) | ||
11-6260004-G-A | not specified | Uncertain significance (Feb 17, 2023) | ||
11-6260037-C-T | Benign (Sep 19, 2018) | |||
11-6260043-T-G | not specified | Uncertain significance (Apr 13, 2023) | ||
11-6260070-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
11-6269701-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
11-6269707-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
11-6269709-C-G | not specified | Uncertain significance (May 12, 2024) | ||
11-6269735-T-C | not specified | Uncertain significance (Nov 15, 2021) | ||
11-6269743-A-G | not specified | Uncertain significance (Mar 21, 2023) | ||
11-6269746-G-T | not specified | Uncertain significance (Mar 01, 2024) | ||
11-6269797-C-T | not specified | Uncertain significance (Jan 31, 2022) | ||
11-6269818-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
11-6269834-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
11-6270078-C-G | Benign (Dec 31, 2019) | |||
11-6270090-G-T | not specified | Uncertain significance (Oct 02, 2023) | ||
11-6270123-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
11-6270133-T-C | not specified | Uncertain significance (Feb 28, 2024) | ||
11-6270219-T-G | not specified | Uncertain significance (Mar 05, 2024) | ||
11-6270286-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
11-6270654-T-C | not specified | Uncertain significance (Oct 27, 2021) | ||
11-6270801-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
11-6271029-G-C | not specified | Uncertain significance (Sep 22, 2023) | ||
11-6271031-C-A | not specified | Uncertain significance (May 27, 2022) | ||
11-6271069-C-A | not specified | Uncertain significance (Mar 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCKBR | protein_coding | protein_coding | ENST00000334619 | 5 | 12392 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000214 | 0.903 | 125696 | 0 | 52 | 125748 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.656 | 276 | 308 | 0.895 | 0.0000216 | 2792 |
Missense in Polyphen | 74 | 99.664 | 0.7425 | 950 | ||
Synonymous | 1.15 | 121 | 138 | 0.875 | 0.00000999 | 1050 |
Loss of Function | 1.63 | 12 | 19.8 | 0.605 | 0.00000140 | 152 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000380 | 0.000380 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000474 | 0.0000462 |
European (Non-Finnish) | 0.000239 | 0.000237 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000294 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for gastrin and cholecystokinin. The CCK-B receptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.;
- Pathway
- Gastric acid secretion - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Proton Pump Inhibitor Pathway, Pharmacodynamics;Pantoprazole Action Pathway;Rabeprazole Action Pathway;Esomeprazole Action Pathway;Omeprazole Action Pathway;Lansoprazole Action Pathway;Gastric Acid Production;Nizatidine Action Pathway;Cimetidine Action Pathway;Famotidine Action Pathway;Ranitidine Action Pathway;Betazole Action Pathway;Roxatidine acetate Action Pathway;Metiamide Action Pathway;Pirenzepine Action Pathway;GPCRs, Other;Peptide GPCRs;Secretion of Hydrochloric Acid in Parietal Cells;Cell-type Dependent Selectivity of CCK2R Signaling;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;Gastrin;Gastrin-CREB signalling pathway via PKC and MAPK;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.156
Intolerance Scores
- loftool
- 0.895
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.6
Haploinsufficiency Scores
- pHI
- 0.443
- hipred
- N
- hipred_score
- 0.421
- ghis
- 0.541
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cckbr
- Phenotype
- liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; renal/urinary system phenotype; homeostasis/metabolism phenotype; immune system phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- gastric acid secretion;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;cell population proliferation;positive regulation of cell population proliferation;cholecystokinin signaling pathway;regulation of phosphatidylinositol 3-kinase activity;digestive tract development;gland development
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- cholecystokinin receptor activity;protein binding;gastrin receptor activity;peptide hormone binding;type B gastrin/cholecystokinin receptor binding;1-phosphatidylinositol-3-kinase regulator activity